Developmental Biology podcasts

This Nature Podcast episode examines human brain organoids transplanted into mice lacking a cerebral cortex, where extensive cellular integration could create an in-vivo platform for testing therapies and studying human neurobiology. It also covers research highlights and Paper2Agent, an AI system that turns research papers into interactive virtual corresponding authors able to answer questions and support complex scientific tasks.

Sarah Crespi and Richard Stone discuss the spread of disease-carrying Hyalomma ticks as the climate changes, drawing on reporting from Kosovo and the role of surveillance. Evolutionary ecologist Veronika Bókony then explains research on agile frogs whose development changes with temperature, including the reproductive consequences for genetically female frogs that develop male traits. The episode connects climate, disease ecology and amphibian reproduction. The publisher supplies a transcript and external audio.

Hosted by Sarah Crespi

Nature staff discuss how a newly approved orexin-targeting narcolepsy drug could enable therapies for other neurological conditions, and examine human brain organoids that have remained viable for more than five years. The episode connects sleep medicine, therapeutic neuroscience, and long-term models of human brain development.

Nature staff revisit the landmark cloning of Dolly the sheep from an adult cell and discuss the first direct observation of ocean-floor crust being created.

Thomas Reh and Juliette Wohlschlegel discuss their research on converting human Müller glia into retinal neurons with host Martin Pera. The conversation traces how regeneration in fish and frogs motivated experiments in mammals, then examines genetic reprogramming of cells derived from human fetal tissue or retinal organoids. Their study of ASCL1-induced neurogenesis provides a basis for discussing the remaining biological and translational challenges of retinal regeneration. The work concerns experimental cellular models and does not establish a treatment for vision loss.

Robert J Johnston joins Jonathan McCrea to explain retinal organoids and how researchers grow these laboratory models of the retina. Drawing on his work at Johns Hopkins University, Johnston discusses what the models can offer basic and translational research, how industry views their use, and whether they could become a standard approach for studying retinal disease. The conversation examines the research potential of lab-grown retinas rather than presenting them as an established treatment.